---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-014468"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T04:28:22.805981+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Ginkgo Bioworks appoints Kathy Hopinkah Hannan to its Board of Directors

## Summary
- Appointment effective August 2, 2022; term expires at 2023 annual meeting.
- Received options to purchase Class A common stock valued at $400,000 plus prorated RSUs and options.
- Eligible for $50,000 annual retainer and annual stock awards under Non-Employee Director Compensation Program.
- Hannan is retired KPMG Vice Chair and serves on boards of NLY, OTIS, and CRS.
- Board determined Dr. Hannan is independent under NYSE listing standards.

## SEC filing metadata
- accession: 0000950170-22-014468
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000095017022014468/0000950170-22-014468-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000095017022014468/dna-20220802.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-014468
- JSON: https://secwatch.observer/filing/0000950170-22-014468.json
- Plain text: https://secwatch.observer/filing/0000950170-22-014468.txt

## Key facts
- Executive change
  Kathy Hopinkah Hannan was appointed as Director at Ginkgo Bioworks Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: On August 2, 2022, the Board of Directors (the “Board”) of Ginkgo Bioworks Holdings, Inc. (the “Company”) voted to appoint Kathy Hopinkah Hannan to the Board, effective as of August 2, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000095017022014468/0000950170-22-014468-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.